IMMUNOASSAYS OF THE METALLOPROTEINASE (MMP-2) AND TISSUE INHIBITOR OF METALLOPROTEINASE (TIMP-1 AND TIMP-2) LEVELS IN NONINVASIVE AND METASTATIC PC-3 CLONES - EFFECTS OF TAXOL

被引:0
|
作者
STEARNS, ME
WANG, M
机构
关键词
METALLOPROTEINASE-MMP-2; TIMP-1-2; PC-3; CLONES; IMMUNOASSAYS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have selected and subcloned bone metastatic (PC-3 ML) and noninvasive, nonmetastatic (3 x N.I) lines from human prostatic PC-3 parent cells. In this paper, we have compared relative levels of MMP-2 and TIMP-1 and 2 in PC-3 tumors grown in severe combined immunodeficient or SCID mice. Dot blots with polyclonal antibodies specific for MMP-2, TIMP-1 and TIMP-2 revealed that the MMP-2 levels were high in subcutaneously grown PC-3 ML clones but low in 3 x N.I. clones at days 20 and 40. The TIMP-1 levels were inversely proportional to MMP-2 in the two types of clones, respectively. The TIMP-2 levels were similar in both clones at days 20 and 40. Gelatin zymograms confirmed that PC-3 ML tumors contained MMP-2 (and not MMP-9) subcutaneously or in bone metastases in SCID mice. Slot blots of PC-3 ML bone tumors comparing MMP-2 and TLMP-1 levels showed at days IO, 15, 17, 19, 21, and 25 that the ratio of MMP-2 to TLMP-1 increased, especially at about day 21, when extensive secondary metastases to the peritoneal cavity occurred. The levels of TIMP-2 remained constant. Quantitative ELISAs confirmed the blotting data and showed that taxol blocked MMP-2 but not TLMP-1 production in these advanced tumors. We conclude that highly metastatic PC-3 ML variants contained relatively high levels of MMP-2 and low amounts of TIMP-1.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 50 条
  • [21] Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer
    Sharma, Kiran L.
    Misra, Sanjeev
    Kumar, Ashok
    Mittal, Balraj
    LIVER INTERNATIONAL, 2012, 32 (08) : 1278 - 1286
  • [22] Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion
    Di Gregoli, Karina
    George, Sarah J.
    Jackson, Christopher L.
    Newby, Andrew C.
    Johnson, Jason L.
    CARDIOVASCULAR RESEARCH, 2016, 109 (02) : 318 - 330
  • [23] Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: associations with clinicopathological variables and patient survival
    Giaginis, Constantinos
    Nikiteas, Nikolaos
    Margeli, Alexandra
    Tzanakis, Nikolaos
    Rallis, Georgios
    Kouraklis, Gregorios
    Theocharis, Stamatios
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (04): : 245 - 252
  • [24] Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2
    Olson, MW
    Gervasi, DC
    Mobashery, S
    Fridman, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) : 29975 - 29983
  • [25] Effect of avocado and soybean unsaponifiables on gelatinase A (MMP-2), stromelysin 1 (MMP-3), and tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2) secretion by human fibroblasts in culture
    Kut-Lasserre, C
    Miller, CC
    Ejeil, AL
    Gogly, B
    Dridi, M
    Piccardi, N
    Guillou, B
    Pellat, B
    Godeau, G
    JOURNAL OF PERIODONTOLOGY, 2001, 72 (12) : 1685 - 1694
  • [26] Matrix metalloproteinase-1 and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in systemic sclerosis
    Kita, K
    Klimiuk, PA
    Lewandowski, B
    Sierakowski, S
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 277 - 277
  • [27] Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C - Comparison using ROC analysis
    Walsh, KM
    Timms, P
    Campbell, S
    MacSween, RNM
    Morris, AJ
    DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (03) : 624 - 630
  • [28] Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2
    M. Fujimura
    M. Watanabe
    H. Shimizu
    T. Tominaga
    Acta Neurochirurgica, 2007, 149 : 179 - 183
  • [29] Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor, TIMP-2, in patients with chronic heart failure
    Kobusiak-Prokopowicz, M.
    Krzysztofik, J.
    Kaaz, K.
    Jolda-Mydlowska, B.
    Mysiak, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 297 - 297
  • [30] Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP-1) in the clinical progression of pediatric acute lymphoblastic leukemia
    Saleh, Maha
    Khalil, Mohamed
    Abdellateif, Mona S.
    Ebeid, Emad
    Madney, Youssef
    Kandeel, Eman Z.
    HEMATOLOGY, 2021, 26 (01) : 758 - 768